2 Hot Stocks to Watch: ServiceNow, Inc. (NYSE:NOW), Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)

ServiceNow, Inc. (NYSE:NOW)

The shares of ServiceNow, Inc. (NYSE:NOW) started off the last trading session with the price of $175.96 while closing the day with the price of $173.83. The shares of ServiceNow, Inc. (NYSE:NOW) Fell -0.86% with the Loss of -2.13 points.

The shares of ServiceNow, Inc. (NYSE:NOW) traded with the day volume of 1.66 Million shares whereas its average trading volume is 1.86 Million.

While analyzing the past performance of the stock we can see that the shares of ServiceNow, Inc. (NYSE:NOW) Gain 0.49% in the last week while rising 17.81% in the last month. Past quarter performance shows the green light with 43.65%. The semi-annual and annual performance shows 49.79% and 96.62% respectively.

Some critical values of the shares of ServiceNow, Inc. (NYSE:NOW) to be discussed here are: the beta which shows the value at 1.13 while Average True Range of ServiceNow, Inc. (NYSE:NOW) demonstrate the value at 4.96. The weekly and monthly volatility of the shares of ServiceNow, Inc. (NYSE:NOW) are indicated at 2.19% and 2.78%. Also to discuss here is the Relative Strength Index or RSI which is depicted at 72.08.

While studying the financial position of the shares of ServiceNow, Inc. (NYSE:NOW), we can see that the Market capitalization of the company is at 30.06 Billion. The shares outstanding for the company is 172.93 Million and the shares float stands at 168.65 Million. The income of the company stand at 115.3 Million while the sales stand at 1.93 Billion.

Here are some critical ratios for a financial perspective: Earnings Per Share or EPS of the company stand at 0.65, Price to Earnings or P/E is at 267.43, Price to Sales P/S show the value of 15.55, the Return on Asset ROA stood at -0.052 and the Return on Equity ROE depicted at -0.292 while Return on Investment ROI is at 0.093.


Keryx Biopharmaceuticals Inc. (NASDAQ:KERX)

Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) started its previous trading session at $4.75 and closed at $4.55 showing a Fell of -3.6 Percent.

The Company traded with an average Volume of 1.35 Million whereas, its Day Volume stood at 1.65 Million.

Looking at the performance of the stock, Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) Loss -7.89% in the last week in its shares price and -1.94% in the last month. Quarterly performance shows a green of 1.79 Percent while Semi-Annual and Annual performances shows a -38.18 and -20.32 percent respectively.

Beta for Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) stands at 2.59 while the ATR (average true range) is at 0.24. The Stock’s Weekly and Monthly Volatility is 4.68% and 4.72% respectively showing a RSI value of 42.41.

While studying the financial position of the shares of Keryx Biopharmaceuticals Inc. (NASDAQ:KERX), we can see that the Market capitalization of the company is at 537.86 Million. The shares outstanding for the company is 118.21 Million and the shares float stands at 117.6 Million.

The Company generated an income of -275100000 and the sales of 60.6 Million in the Trailing Twelve Months period.

While analyzing the stock from technical aspects, Diluted Earnings per share stands at $-2.37 a share. P/E (price to earnings) and P/S (price to sales) values are 0 and 8.88 respectively.

The Return on Assets stands at -1.014, ROE shows a value of 0 and ROI for Keryx Biopharmaceuticals Inc. (NASDAQ:KERX) is -1.901 as of Trailing Twelve Months period.

View all contributions by

Eldred Matthew covers Healthcare Sector Company recent Press Releases news updates. He has three year of experience in content writing as freelance writer. He performs analysis of Healthcare Companies and provides worthy information for investor community. He is an experienced writer with a precise grasp of the English language and a clear, compelling writing style.

    Leave a Comment